Scientists Uncover Worrying Link Between This Popular Erection Drug and Blindness

Key Points:

• New research from Taiwan indicates that tadalafil, the active ingredient in Cialis, is linked to a 22% increased risk of developing glaucoma over five years compared to non-users, based on a study of nearly 37,000 men over 40 taking the drug for urinary tract symptoms.
• Tadalafil and similar phosphodiesterase type 5 inhibitors (PDE5is), while primarily used for erectile dysfunction, are also prescribed for other conditions like enlarged prostate symptoms, often at lower daily doses.
• The study found a slightly higher incidence of glaucoma (3.93% vs. 3.16%) and ocular hypertension among tadalafil users, though these vision-related side effects remain relatively rare overall.
• Researchers recommend that doctors monitor patients on PDE5is for potential vision complications, especially those with existing glaucoma risk factors, and call for further studies to clarify the mechanisms behind these drug-related eye risks.
• Despite these findings, PDE5is continue to be valuable treatments for multiple conditions, and awareness of potential irreversible glaucoma side effects can help guide safer prescribing practices.